Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
aducanumab, AE, AEs, arm, blinded, blockade, blood, body, bradykinesia, cardinal, censored, central, centrally, cerebral, clearance, clinician, CNS, cognitive, cognitively, comparison, Conference, Daily, descriptive, dopaminergic, England, estate, examination, fibrillar, gait, hazard, immune, immunization, immunized, Immunohistochemistry, implicated, impression, infusion, levodopa, Living, magnetic, MDS, mg, mild, MIV, MoCA, moderate, molecule, Montreal, motor, NCT, neutralizing, oligomeric, plaque, polyclonal, pooled, potency, presence, putamen, randomized, ratio, reached, real, regimen, resting, rigidity, sample, saturate, Schwab, screening, sera, slope, small, smartphone, Society, soluble, spin, stable, subset, subtenant, suggesting, therapy, thought, titer, toxic, tremor, unmet, worsening
Removed:
cancellation, prepaid
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 EX-10.1 3RD Amendment to 2020 Eiip
- 31.1 Exhibit 31.1 Certification of Chief Executive Officer Pursuant to Section 302
- 31.2 Exhibit 31.2 Certification of Chief Financial Officer Pursuant to Section 302
- 32.1 Exhibit 32.1 Section 906 Certification
- Download Excel data file
- View Excel data file
Related press release
PRTA similar filings
Filing view
External links